« May 12, 2020 | Main | May 15, 2020 »
May 13, 2020
Cipla Enters Into a Licensing Agreement With Gilead to Expand Access to COVID-19 Treatment
MUMBAI, India, May 13, 2020 — Cipla Limited today announced that it had signed a non-exclusive licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribution of the investigational medicine Remdesivir. This agreement is part of Cipla’s efforts to enhance global access to life-saving treatments for patients affected by the pandemic. Remdesivir has been issued an Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) to treat COVID-19 patients.
As part of the agreement, Gilead Sciences would permit Cipla to manufacture the API (Active Pharmaceutical Ingredient) and Finished Product and market it in 127 countries, including India and South Africa, under Cipla’s brand name. Cipla will receive the manufacturing know-how from Gilead Sciences, Inc. to manufacture the API and Finished Product at a commercial scale. Cipla’s extensive geographical and retail footprint will help make this therapy accessible to more patients and markets.
According to the World Health Organisation (WHO)’s tracker, the number of reported COVID-19 cases has crossed the four million mark globally.
The EUA will facilitate the broader use of Remdesivir to treat hospitalized patients with severe symptoms of COVID-19. The EUA is based on available data from two global clinical trials - the U.S. National Institute for Allergy and Infectious Diseases’ placebo-controlled Phase 3 study in patients with moderate to severe symptoms of COVID-19, and Gilead’s global Phase 3 study evaluating Remdesivir in patients with severe disease. Multiple additional clinical trials are ongoing to generate more data on the safety and efficacy of Remdesivir as a potential treatment for COVID-19. Remdesivir continues to be an investigational drug that has not been approved by the FDA.
Commenting on the partnership, Mr. Umang Vohra, MD and Global CEO, Cipla Limited, said, “As the world faces the COVID-19 crisis, we must collaborate and fight this virus together. We are pleased to partner with Gilead for this cause and take this treatment to patients across countries after the required regulatory approvals. At Cipla, it is our continuous endeavor to ensure that no patient is denied access to life-saving treatments. Our partnership with Gilead represents this unwavering commitment and is a significant step towards saving millions of lives impacted by the pandemic.”
Source: Cipla.
|GlobalGiants.Com|
Edited & Posted by the Editor | 1:31 PM | View the original post
Lucy Hale Joins ALMAY As Global Brand Ambassador
Photo: Lucy Hale for ALMAY.
NEW YORK, May 12, 2020 — ALMAY, a leader in clean, hypoallergenic makeup, has announced its partnership with multi-talented actress and singer Lucy Hale. She will take on the role of ALMAY Global Brand Ambassador.
“Known for her versatile skill set, Hale has captured millions of viewers around the world with her roles on multiple smash-hit TV shows. With ALMAY, Hale will now take on her newest role, inviting fans to join her sensitive skin journey and learn about her clean beauty routine,” ALMAY said in an announcement.
“I’m a beauty and skincare lover at heart, but I’ve always struggled with finding the right products for my sensitive skin,” says Lucy Hale. “For someone who has and still deals with skin issues, it’s so important that from start to finish, I keep my beauty routine as gentle as possible, which is why I love ALMAY products. From their eyeliners to their mascaras to their makeup remover towelettes, ALMAY uses gentle ingredients in products specially formulated to avoid irritation. They’re the perfect solution for me - easy to use, high-quality products that don’t sacrifice performance.”
ALMAY said Hale believes it is up to all of us to have as minimal of an impact on the planet as possible and that biodegradable, clean products are the future. Starting last year, ALMAY has taken steps towards minimizing its effect on the earth by incorporating eco-friendly, sustainable elements into their packaging to help provide for a better tomorrow.
“Lucy embodies ALMAY’s approach to effortless beauty. She’s knowledgeable about what she applies to her sensitive skin and knows that using gentle formulas with carefully selected ingredients doesn’t mean she has to compromise on payoff or performance,” said Global Brand President Silvia Galfo. “Lucy embraces our brand values of clean, effortless, hypoallergenic beauty in her daily life and is the perfect partner to inspire women to feel their best and be confident, no matter their skin needs. We couldn’t be more thrilled to welcome her to the ALMAY family.”
As Global Brand Ambassador, Hale will act as the face of ALMAY in a series of upcoming campaigns, including the launch of a series of yet-to-be-revealed products this winter.
According to ALMAY, it has been the leader in hypoallergenic makeup since 1931 with the belief that beauty should be clean, effortless, and have nothing to hide.
Source: ALMAY.
|GlobalGiants.Com|
Edited & Posted by the Editor | 3:05 AM | View the original post
